Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibodies
Biotech
Boehringer's deal frenzy continues with $570M autoimmune pact
The German pharma is turning to established partner CDR-Life for a new trispecific autoimmune antibody.
Darren Incorvaia
Nov 4, 2025 8:00am
Celltrion pens $744M pact for 2 preclinical autoimmune drugs
Nov 4, 2025 6:15am
Regeneron pledges $1B+ for ModeX multispecific antibodies
Oct 29, 2025 11:04am
Otsuka inks $613M deal for Swedish biotech's IL1RAP antibodies
Jul 16, 2025 1:37pm
Concentra strikes again, circling up IGM Biosciences
Jul 1, 2025 9:58am
Pfizer shares prostate cancer data after leak, inks Alloy deal
Feb 11, 2025 1:07pm